Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Claxton

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Critical Reviews in Immunology|October 20, 2001
Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progressD F Claxton, J McMannis, R Champlin, et al.
Critical Reviews in Immunology|January 7, 1998
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicityA Choudhury, A Toubert, S Sutaria, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical lociH Liang, J Fairman, D F Claxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1995
PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cellsS Fu, U Consoli, E G Hanania, et al.
Bone Marrow Transplantation|February 11, 2009
BU and CY as conditioning regimen for autologous transplant in patients with multiple myelomaG Talamo, D F Claxton, D W Dougherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 1996
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter propertiesC S Zent, C Mathieu, D F Claxton, et al.
Genomics|October 1, 1993
Smooth muscle myosin heavy chain locus (MYH11) maps to 16p13.13-p13.12 and establishes a new region of conserved synteny between human 16p and mouse 16Z Deng, P Liu, P Marlton, et al.
Science (New York, N.Y.)|August 20, 1993
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemiaP Liu, S A Tarlé, A Hajra, et al.
Oncogene|October 7, 1997
CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cellsW Cao, M Britos-Bray, D F Claxton, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Apoptosis. Molecules and mechanismsM Konopleva, S Zhao, Z Xie, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Critical Reviews in Immunology|October 20, 2001
Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progressD F Claxton, J McMannis, R Champlin, et al.
Critical Reviews in Immunology|January 7, 1998
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicityA Choudhury, A Toubert, S Sutaria, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical lociH Liang, J Fairman, D F Claxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1995
PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cellsS Fu, U Consoli, E G Hanania, et al.
Bone Marrow Transplantation|February 11, 2009
BU and CY as conditioning regimen for autologous transplant in patients with multiple myelomaG Talamo, D F Claxton, D W Dougherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 1996
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter propertiesC S Zent, C Mathieu, D F Claxton, et al.
Genomics|October 1, 1993
Smooth muscle myosin heavy chain locus (MYH11) maps to 16p13.13-p13.12 and establishes a new region of conserved synteny between human 16p and mouse 16Z Deng, P Liu, P Marlton, et al.
Science (New York, N.Y.)|August 20, 1993
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemiaP Liu, S A Tarlé, A Hajra, et al.
Oncogene|October 7, 1997
CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cellsW Cao, M Britos-Bray, D F Claxton, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Apoptosis. Molecules and mechanismsM Konopleva, S Zhao, Z Xie, et al.
Pageof 2